SCHEMBL13848641

SCHEMBL13848641

CC(C)/C=C1\CCCN(C)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.43
BRD2 P25440 1/20 0.43
INMT O95050 2/20 0.39
MEN1 O00255 5/20 0.35
MAPT P10636 5/20 0.35
KMT2A Q03164 5/20 0.35
GAA P10253 3/20 0.35
RAB9A P51151 3/20 0.35
ALDH1A1 P00352 3/20 0.35
PSMD14 O00487 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PIK3CD O00329 1/20 0.32
NPC1 O15118 2/20 0.31
KDM4E B2RXH2 1/20 0.31
IDE P14735 1/20 0.31
LMNA P02545 1/20 0.31
MAPK1 P28482 1/20 0.31
MCOLN3 Q8TDD5 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19481284 0.76 INMT (0.38) BRD4BRD2INMT
SCHEMBL17459703 0.75 INMT (0.33) INMTMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL17459701 0.75 INMT (0.33) INMTMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL12640776 0.71 INMT (0.44) BRD4BRD2INMTMEN1MAPT
SCHEMBL10735746 0.70 MAPT (0.47) MEN1MAPTKMT2AGAARAB9A
SCHEMBL17459688 0.69 BRD4 (0.35) BRD4MEN1MAPTKMT2ARAB9A
SCHEMBL17459686 0.69 BRD4 (0.35) BRD4MEN1MAPTKMT2ARAB9A
SCHEMBL4827581 0.69 RAB9A (0.39) MEN1MAPTKMT2AGAARAB9A
SCHEMBL1076577 0.69 ALDH1A1 (0.41) MEN1MAPTKMT2ARAB9AALDH1A1
SCHEMBL6387239 0.69 ALDH1A1 (0.41) MEN1MAPTKMT2ARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090131481-A1 Transcription Factor Modulating Compounds and Methods of Use Thereof PARATEK PHARMACEUTICALS, INC. (US) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131481-A1 Transcription Factor Modulating Compounds and Methods of Use Thereof CREBBP, JUN, IRF3 BRD4 109/4885BRD2 227/4885INMT 1439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.